Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro-Reference-Cited by-同舟云学术

Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro

Published:1993-11 Issue:3 Volume:26 Page:197-202
ISSN:0162-3109
Container-title:Immunopharmacology
language:en
Short-container-title:Immunopharmacology

Author:

Górski Andrzej,Grieb Paweł,Korczak-Kowalska Grażyna,Wierzbicki Piotr,Stȩpień-Sopniewska Barbara,Mrowiec Tomasz

Publisher

Elsevier BV

Subject

Pharmacology

Reference17 articles.

1. The new era of immunosuppressive therapy in autoimmune diseases;Bach,1991

2. Cladribine (2-chlorodeoxyadenosine);Beutler;Lancet,1992

3. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo;Carrera;J Clin Invest,1990

4. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo;Carson,1980

5. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes;Carson;Blood,1983

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Other Forms of Immunosuppression;Kidney Transplantation - Principles and Practice;2019

2. Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells;Journal of Neurology;2018-03-17

3. Other Forms of Immunosuppression;Kidney Transplantation–Principles and Practice;2014

4. Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity;Journal of Neuroimmunology;2011-12

5. Other Forms of Immunosuppression;Kidney Transplantation;2008